Ventures Llc Remeditex serves as Executive at BELLICUM PHARMACEUTICALS, INC, where they oversee executive responsibilities. Since joining the company, Ventures Llc Remeditex has executed 13 insider transactions totaling $2.7M, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 16, 2021 involved selling 9,214,277 shares valued at $208.2M.
Ventures Llc Remeditex currently holds 9,214,277 shares of BELLICUM PHARMACEUTICALS, INC (BLCM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ventures Llc Remeditex has been a net buyer of BLCM stock. They have purchased $2.7M and sold $0 worth of shares.
Ventures Llc Remeditex's most recent insider trade was on Dec 16, 2021, when they sold 9,214,277 shares at $22.60 per share.
Get notified when new Form 4 filings are submitted
| $8.30 |
| Discretionary |
| Dec 29, 2019 | APEN | $0 | Other | 1,309,392 | $N/A | Discretionary |
| Oct 11, 2019 | SOLY | $0 | Purchase | 155,280 | $N/A | Discretionary |
| Jun 19, 2019 | SOLY | $0 | Purchase | 357,143 | $N/A | Discretionary |
| Jan 29, 2018 | MNLO | $0 | Conversion | 304,576 | $N/A | Discretionary |
| Jan 29, 2018 | MNLO | $0 | Conversion | 871,583 | $N/A | Discretionary |
| Jan 29, 2018 | MNLO | $0 | Conversion | 2,650 | $N/A | Discretionary |
| Jan 25, 2018 | MNLO | $1.7M | Purchase | 100,000 | $17.00 | Discretionary |
| Dec 23, 2014 | BLCM | $0 | Conversion | 1,359,297 | $N/A | Discretionary |
| Dec 23, 2014 | BLCM | $0 | Conversion | 159,444 | $N/A | Discretionary |
| Dec 23, 2014 | BLCM | $0 | Conversion | 245,299 | $N/A | Discretionary |
| Dec 23, 2014 | BLCM | $0 | Other | 43,563 | $N/A | Discretionary |